ritanserin has been researched along with Body Weight in 6 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of mCPP (1-(m-chlorophenyl)piperazine) (2 mg/kg bid, i." | 1.31 | Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs. ( Arjona, AA; Lee, RK; Pooler, AM; Wurtman, RJ, 2002) |
| "Ritanserin is a thymosthenic agent with an extensive hepatic metabolism and long elimination half life in healthy volunteers." | 1.29 | Ritanserin pharmacokinetics in abstinent chronic alcoholics. ( Estévez, F; Giusti, M; Monti, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arjona, AA | 1 |
| Pooler, AM | 1 |
| Lee, RK | 1 |
| Wurtman, RJ | 1 |
| Estévez, F | 1 |
| Giusti, M | 1 |
| Monti, J | 1 |
| Squadrito, F | 1 |
| Calapai, G | 1 |
| Cucinotta, D | 1 |
| Altavilla, D | 1 |
| Zingarelli, B | 1 |
| Ioculano, M | 1 |
| Urna, G | 1 |
| Sardella, A | 1 |
| Campo, GM | 1 |
| Caputi, AP | 1 |
| Bollweg, G | 1 |
| Sparber, SB | 1 |
| Almeida, SS | 1 |
| de Oliveira, LM | 1 |
| Graeff, FG | 1 |
| Nabeshima, T | 1 |
| Hiramatsu, M | 1 |
| Yamaguchi, K | 1 |
| Kasugai, M | 1 |
| Ishizaki, K | 1 |
| Kawashima, K | 1 |
| Itoh, K | 1 |
| Ogawa, S | 1 |
| Katoh, A | 1 |
| Furukawa, H | 1 |
6 other studies available for ritanserin and Body Weight
| Article | Year |
|---|---|
Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Body Weight; Brai | 2002 |
Ritanserin pharmacokinetics in abstinent chronic alcoholics.
Topics: Adult; Alcoholism; Body Weight; Chromatography, Liquid; Female; Humans; Male; Metabolic Clearance Ra | 1995 |
Anorectic activity of NG-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats.
Topics: Amino Acid Oxidoreductases; Animals; Appetite Depressants; Arginine; Body Weight; Brain; Eating; Mal | 1993 |
Relationships between midembryonic 5-HT2 agonist and/or antagonist exposure and detour learning by chickens.
Topics: Amphetamines; Animals; Behavior, Animal; Body Weight; Chick Embryo; Chickens; Female; Humans; Learni | 1998 |
Decreased reactivity to anxiolytics caused by early protein malnutrition in rats.
Topics: Animals; Anti-Anxiety Agents; Body Weight; Diazepam; Diet; Dose-Response Relationship, Drug; Hyperto | 1990 |
Effects of prenatal administration of phencyclidine on the learning and memory processes of rat offspring.
Topics: Animals; Avoidance Learning; Body Weight; Brain; Female; Learning; Memory; Naloxone; Organ Size; Phe | 1988 |